comparemela.com

Latest Breaking News On - Malcolm whitten - Page 1 : comparemela.com

Pros And Cons Of Insurance Companies

5 outperforming ASX dividend shares unmasked

5 outperforming ASX dividend shares unmasked With bank deposit rates and bond yields in the cellar, ASX dividend shares are in the spotlight Bernd Struben earned his economics degree in the US. Following several years writing about the tourism industry in the Caribbean, he moved to The Netherlands to cover the EU s booming commercial real estate markets. He moved to Australia in 2010, where he transitioned to analysing the Aussie equity markets. He employs a combination of macro economics and company specific data to gauge what he believes are tomorrow s best investments. In his free time, you re likely to find Bernd at the beach or dabbling away on a new work of science fiction.

China
Australia
Yarra
New-south-wales
Iluka
United-kingdom
Michael-maughan
Malcolm-whitten
Oz-minerals
Aska-fund
Nikko-am-australian-share-income-fund
Motley-fool

Big banks to fuel next leg of ASX dividend spree

Which funds benefit from IOOF's acquisition?

Print There are four funds set to benefit from the completion of the acquisition of MLC Wealth by IOOF from National Australia Bank (NAB).  Yesterday, NAB completed its sale of MLC Wealth to IOOF, doubling the size of IOOF’s business to $494 billion in funds under management and an additional 406 MLC advisers would join the firm. The deal had first been confirmed  at the end of August 2020.   After a dip at the start of the year following the announcement that it had lost $400 million in funds under management, advice and administration, shares in IOOF had risen 15% since the start of the year to 28 May, 2021. This compared to returns of 10.6% by the ASX 200.  

Australia
Yarra
New-south-wales
Malcolm-whitten
National-australia-bank
Oc-premium-small-companies
Lazard-defensive-australian-equity
Small-companies
Vaneck-small-cap-dividend-payers
Nikko-australian-share
Yarra-capital-management
ஆஸ்திரேலியா

Why CSL is still a buy | Money Management

Nevertheless, Australian equities manager Malcolm Whitten from Tyndall Asset Management and Marcus Bogdan from Blackmore Capital were optimistic on the business. “We think CSL is fair value, it was a safe haven in COVID-19 and a potential vaccine supplier. But on the re-opening, it underperformed, and that underperformance created opportunities to re-enter the stock,” said Whitten, who managed the Nikko AM Australian Shares Income fund. “While it was in lockdown, people were scared to go out and donate blood so the lack of blood availability constrained supply. But now the fading effects of the welfare payments in the US should mean supply increases; when there is high unemployment then blood donations increase.

Australia
Australian
Marcus-bogdan
Malcolm-whitten
Pfizer
Astrazeneca
University-of-queensland
Tyndall-asset-management
Blackmore-capital
Shares-income
Csl
Astrazeneca

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.